These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35496732)

  • 21. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric dermatofibrosarcoma protuberans: A clinicopathologic and genetic analysis of 66 cases in the largest institution in Southwest China.
    Zhang Z; Lu Y; Shi C; Chen M; He X; Zhang H
    Front Oncol; 2023; 13():1017154. PubMed ID: 36776313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual presentation of dermatofibrosarcoma protuberans: A case of fibrosarcomatous dermatofibrosarcoma protuberans with pleomorphic angiectatic tumor-like changes.
    Yoshida KI; Fujii J; Honma K; Nakai S
    J Cutan Pathol; 2024 Aug; 51(8):609-613. PubMed ID: 38711216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls.
    Trinidad CM; Wangsiricharoen S; Prieto VG; Aung PP
    Dermatopathology (Basel); 2023 Jan; 10(1):54-62. PubMed ID: 36810566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion.
    Lu Y; Li T; Chen M; Peng H; Du T; Qiu Y; Zhang H
    Virchows Arch; 2022 Aug; 481(2):313-319. PubMed ID: 35171326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: a case report.
    Hrudka J; Charvát M; Grossmann P; Kinkor Z
    Cesk Patol; 2020; 56(2):89-93. PubMed ID: 32493025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations.
    Campbell K; Bridge JA; DiMaio D; Wilson J; Shalin SC; Gardner JM
    J Cutan Pathol; 2022 Mar; 49(3):274-277. PubMed ID: 34628665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review.
    Banach BS; Antic T; Bridge JA; Cipriani NA; Frye L; Krausz TN; Biernacka A
    Diagn Cytopathol; 2019 Aug; 47(8):797-802. PubMed ID: 30919592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leiomyomatous nodules and bundles of vascular origin in the fibrosarcomatous variant of dermatofibrosarcoma protuberans.
    Sanz-Trelles A; Ayala-Carbonero A; Rodrigo-Fernández I; Weil-Lara B
    J Cutan Pathol; 1998 Jan; 25(1):44-9. PubMed ID: 9508343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Osaki J; Ono T; Adachi Y; Tsuchiya R; Toda Y; Ogura K; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2023 Nov; 36(6):2187-2194. PubMed ID: 37490236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger.
    Jha P; Moosavi C; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Apr; 11(2):81-8. PubMed ID: 17349565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
    Wang J; Morimitsu Y; Okamoto S; Hisaoka M; Ishida T; Sheng W; Hashimoto H
    J Mol Diagn; 2000 Feb; 2(1):47-52. PubMed ID: 11272901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion.
    Bianchini L; Maire G; Guillot B; Joujoux JM; Follana P; Simon MP; Coindre JM; Pedeutour F
    Virchows Arch; 2008 Jun; 452(6):689-96. PubMed ID: 18253748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.
    Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H
    Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.
    Salgado R; Llombart B; M Pujol R; Fernández-Serra A; Sanmartín O; Toll A; Rubio L; Segura S; Barranco C; Serra-Guillén C; Yébenes M; Salido M; Traves V; Monteagudo C; Sáez E; Hernández T; de Álava E; Llombart-Bosch A; Solé F; Guillén C; Espinet B; López-Guerrero JA
    Genes Chromosomes Cancer; 2011 Jul; 50(7):510-7. PubMed ID: 21484928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrosarcomatous pigmented dermatofibrosarcoma protuberans: A case report with review of the literature.
    Ishida M; Okabe H
    Oncol Lett; 2012 Sep; 4(3):390-392. PubMed ID: 23741240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
    Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
    Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.
    Saeki H; Hoashi T; Tada Y; Ashida R; Kuwano Y; Le Pavoux A; Tsunemi Y; Shikada J; Torii H; Kawabata Y; Kikuchi K; Tamada Y; Matsumoto Y; Tamaki K
    J Dermatol Sci; 2003 Dec; 33(3):161-7. PubMed ID: 14643521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.